StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / ifastdiagnostics.com

iFAST Diagnostics

iFAST Diagnostics (ifastdiagnostics.com): 3 changes recorded in its website history since April 2023.

The website did not answer the latest live check. Last tried 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. ComplianceBetween and

    Now states ISO 13485 compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. FundingBetween and

    Announced on its homepage: “iFAST Diagnostics announces $6.5M (£5m) to combat antimicrobial resistance globally Seed round raises $6.5m (£5m) from existing investors…”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. FundingBetween and

    Announced on its homepage: “Get in touch Watch our videos iFAST Diagnostics announces $6.5M (£5m) to combat antimicrobial resistance globally Seed round raises $6.5m…”.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 2 April 2023

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

iFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market. We have a test that is up to 10x faster and cheaper than the gold standard, delivering results in 4 hours fo

Homepage

Funding statements on the website
He has raised over £20m in funding and had 5 successful exits along the way.

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. April 2023 – August 2026 · 6 captures · latest observed messagingiFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market.

    This wording observed 16 August 2026.

    archived page
    Inspect 6 captures in this group
    • 2 April 2023 · iFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market. We have a test that is up to 10x faster and cheaper than the gold standard, delivering results in 4 hours fo archived page
    • 11 December 2023 · iFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market. We have a test that is up to 10x faster and cheaper than the gold standard, delivering results in 4 hours fo archived page
    • 28 February 2024 · iFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market. We have a test that is up to 10x faster and cheaper than the gold standard, delivering results in 4 hours fo archived page
    • 18 July 2024 · iFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market. archived page
    • 16 February 2025 · iFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market. archived page
    • 16 August 2026 · iFAST is addressing the $4bn (& growing) Antimicrobial Susceptibility Testing (AST) market. archived page

Cite this record

StartupHistory, “iFAST Diagnostics” company record, https://startuphistory.org/c/ifastdiagnostics.com

Machine-readable: /c/ifastdiagnostics.com.json. How changes are found: method.